Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
11.85
-0.52 (-4.20%)
Mar 31, 2025, 1:11 PM EDT - Market open
Zymeworks Revenue
In the year 2024, Zymeworks had annual revenue of $76.30M with 0.38% growth. Zymeworks had revenue of $31.03M in the quarter ending December 31, 2024, with 83.33% growth.
Revenue (ttm)
$76.30M
Revenue Growth
+0.38%
P/S Ratio
12.30
Revenue / Employee
$266,797
Employees
286
Market Cap
824.49M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 76.30M | 292.00K | 0.38% |
Dec 31, 2023 | 76.01M | -336.47M | -81.57% |
Dec 31, 2022 | 412.48M | 385.80M | 1,446.03% |
Dec 31, 2021 | 26.68M | -12.27M | -31.50% |
Dec 31, 2020 | 38.95M | 9.41M | 31.84% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ZYME News
- 5 days ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 5 days ago - Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting - GlobeNewsWire
- 24 days ago - Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251 - Benzinga
- 25 days ago - Zymeworks Inc. (ZYME) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration - GlobeNewsWire
- 5 weeks ago - Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors - GlobeNewsWire
- 6 weeks ago - Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025 - GlobeNewsWire